February 1st 2023
Iktos, a new CARE partner
Iktos, a new partner of CARE consortium
CARE is welcoming Iktos as a new consortium member.
Iktos is developing artificial intelligence solutions for medicinal chemistry and new drug design.
Iktos will contribute to CARE by building in silico models predicting molecule activity in biological assays and designing molecules with predicted profile converging towards the desired profile for preclinical candidates.
Iktos’s contributions will further bolster the development of therapeutics against coronaviruses in CARE.